Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
VANGUARD GROUP INC IRWD Ironwood Pharmaceuticals Inc 13G/A 10.27% 2y
JPMORGAN CHASE & CO JBL Jabil Inc 13G 7.1% 2y
Invesco Ltd. SUN Sunoco LP 13G/A 1.5% 2y
JPMORGAN CHASE & CO MSA MSA Safety Inc 13G 5.4% 2y
Capital World Investors ADNT Adient plc 13G/A 1.1% 2y
Capital International Investors MSTR Strategy Inc 13G/A 10.5% 2y
WELLINGTON MANAGEMENT GROUP LLP FOUR Shift4 Payments, Inc. 13G/A 7.62% 2y
U.S. Global Jets ETF HA Hawaiian Holdings, Inc. 13G 0% 2y
Vector Capital Management, L.P. LPSN Liveperson Inc 13G 12% 2y
Peter E. Haas, Jr. LEVI Levi Strauss & Co 13G/A 6.9% 2y
Peter E. Haas Jr. Family Fund * LEVI Levi Strauss & Co 13G 19.2% 2y
BROWNING WEST LP GIL Gildan Activewear Inc. 13D/A 5% 2y
Chemung Canal Trust Company E.I. No. CHMG Chemung Financial Corp 13G/A 8.35% 2y
Charmquark TWEE HYFT MindWalk Holdings Corp. 13G/A 6.28% 2y
Charmquark TWEE HYFT MindWalk Holdings Corp. 13G 6.4% 2y
William Charters RGS Regis Corp 13D 3.51% 2y
Yoda PLC CCEC Capital Clean Energy Carriers Corp. 13D/A 21.7% 2y
GENTEX CORP VOXX VOXX International Corporation Class A 13D/A 16.24% 2y
Beat M. Kahli VOXX VOXX International Corporation Class A 13D/A 15.4% 2y
CMLS Holdings II LLC SLGC SomaLogic, Inc. Class A Common Stock 13D/A 0% 2y
BIOTECHNOLOGY VALUE FUND L P KYMR Kymera Therapeutics, Inc. 13D/A 9.99% 2y
Qiming U.S. Healthcare Fund II, L.P. ELEV Elevation Oncology, Inc. Common stock 13G/A 0% 2y
Oaktree Capital Holdings, LLC TRMD TORM plc 13D/A 58.6% 2y
Casdin Capital, LLC LAB Standard Biotools Inc. 13D/A 19.71% 2y
VIKING GLOBAL INVESTORS LP LAB Standard Biotools Inc. 13G 9.5% 2y
James H. Dahl AXR Amrep Corp. 13D/A 14.6% 2y
MILLENNIUM MANAGEMENT LLC MBLY Mobileye Global Inc. 13G 6.2% 2y
Richard E. Fearon, Jr. TACT Transact Technologies Inc 13D 5.29% 2y
Viessmann Generations Group GmbH & Co. KG CARR CARRIER GLOBAL Corp 13D 6.53% 2y
Senvest Management, LLC TSEM Tower Semiconductor Ltd 13G 6.5% 2y
TRAFELET REMY W ALCO Alico, Inc. 13G/A 3.5% 2y
Empery Asset Management, LP NVVE Nuvve Holding Corp. 13G 9.99% 2y
Empery Asset Management, LP SOBR SOBR Safe, Inc. 13G 6.09% 2y
Inlight Wealth Management, LLC IVFH Innovative Food Holdings Inc 13G/A 7.3% 2y
MEITAV INVESTMENT HOUSE LTD GILT Gilat Satellite Networks Ltd 13G/A 8.35% 2y
AIMS Asset Management Sdn Bhd USAU U.S. Gold Corp. 13G/A 6.3% 2y
American Century Investment Management, Inc. CFFN Capitol Federal Financial, Inc. 13G/A 6.58% 2y
Private Capital Management, LLC HROW Harrow, Inc. 13G 10.34% 2y
MILLENNIUM MANAGEMENT LLC ITOS iTeos Therapeutics, Inc. Common Stock 13G/A 2.7% 2y
Empery Asset Management, LP ELEV Elevation Oncology, Inc. Common stock 13G 6.7% 2y
SwissMarine Pte. Ltd. PANL Pangaea Logistics Solutions Ltd. 13G/A 3.07% 2y
Karpus Management, Inc. ENER Accretion Acquisition Corp. Common Stock 13G/A 0% 2y
BAUPOST GROUP LLC/MA ATRA Atara Biotherapeutics, Inc. 13G/A 0% 2y
Karpus Management, Inc. MOBV Mobiv Acquisition Corp Class A Common Stock 13G/A 0% 2y
HighCape Capital, L.P. ELUT Elutia Inc. 13D/A 48.7% 2y
Orin Hirschman DCTH Delcath Systems, Inc. 13G 6.8% 2y
Trigran Investments, Inc. BCOV Brightcove, Inc. 13G/A 10.3% 2y
Minerva Advisors LLC GOVB Gouverneur Bancorp, Inc. 13G 7.1% 2y
Funicular Funds, LP FBRX Forte Biosciences, Inc. 13D/A 5.59% 2y
Saba Capital Management, L.P. EMO ClearBridge Energy Midstream Opportunity Fund Inc. 13G 23.52% 2y